SGLT2i are Cardiovascular Drugs

Open Access

SGLT2i are Cardiovascular Drugs

Session: Time to Take the Lead – Practical Utilization of SGLT2 Inhibitors

Topic: Pharmacotherapy

Speaker: Professor J. Butler (Dallas, US)

Organised by Radcliffe Medical Education, supported by Boehringer Ingelheim & Eli Lilly and Company Alliance in the form of an educational grant

Event: ESC Congress 2020

Congress Presentation

About the speaker

Professor Javed Butler

Baylor Scott & White Health, Dallas (United States of America)

109 presentations

15 followers

4 more presentations in this session

Session Introduction.

Speaker: Professor J. Butler (Dallas, US)

Access

Video

No Permission Needed.

Speaker: Doctor S. Zieroth (Winnipeg, CA)

Access

Video

Cardiologist Taking the Lead – Practical Initiation and Management

Speaker: Professor S. Anker (Berlin, DE)

Access

Video

Live panel discussion and close.

Speaker: Doctor S. Zieroth (Winnipeg, CA) Professor J. Butler (Dallas, US) Professor S. Anker (Berlin, DE)

Access

Video

Access the full session

Time to Take the Lead – Practical Utilization of SGLT2 Inhibitors

Speakers: Professor J. Butler, Professor J. Butler, Doctor S. Zieroth, Professor S. Anker, Doctor S. Zieroth...

Access

Video

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

SGLT2i are Cardiovascular Drugs

About the speaker

Professor Javed Butler

4 more presentations in this session

Session Introduction.

No Permission Needed.

Cardiologist Taking the Lead – Practical Initiation and Management

Live panel discussion and close.

Access the full session

Time to Take the Lead – Practical Utilization of SGLT2 Inhibitors

About the event

ESC Congress 2020

ESC 365 is supported by